Perspective Therapeutics (CATX) Debt to Equity (2023 - 2025)
Perspective Therapeutics (CATX) has disclosed Debt to Equity for 3 consecutive years, with $0.01 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 35.56% to $0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.01 through Dec 2025, up 35.56% year-over-year, with the annual reading at $0.01 for FY2025, 35.56% up from the prior year.
- Debt to Equity hit $0.01 in Q4 2025 for Perspective Therapeutics, up from $0.01 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.02 in Q4 2023 to a low of $0.0 in Q2 2024.
- Historically, Debt to Equity has averaged $0.01 across 3 years, with a median of $0.01 in 2024.
- Biggest five-year swings in Debt to Equity: plummeted 74.92% in 2024 and later surged 35.56% in 2025.
- Year by year, Debt to Equity stood at $0.02 in 2023, then plummeted by 74.92% to $0.01 in 2024, then skyrocketed by 35.56% to $0.01 in 2025.
- Business Quant data shows Debt to Equity for CATX at $0.01 in Q4 2025, $0.01 in Q3 2025, and $0.01 in Q2 2025.